Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine dose-finding for pediatric echocardiography sedation in congenital heart disease
ChiCTR-OPC-17012665Phase 4Not yet recruiting
- Sponsor
- Children's Hospital of Chongqing Medical University
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine in Cardiovascular Malformation (CVM) (2 cohorts), sponsored by Children's Hospital of Chongqing Medical University. Primary endpoints: Heart rate, Oxygen saturation and 1 more. Planned start Sep 2017; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on ChiCTR-OPC-17012665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-17012665.